Source: Annual Congress 2004 - Lung transplantation: update on clinical and experimental issues
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Ward, I. A. Forrest, H. Robertson, D. M. Murphy, G. Pritchard, J. L. Lordan, T. E. Cawston, J. A. Kirby, P. A. Corris (Newcastle-upon-Tyne, United Kingdom). Epithelial mesenchymal transition in lung allografts. Eur Respir J 2004; 24: Suppl. 48, 1149

Member's Comments

No comment yet.

Related content which might interest you: Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis Source: Eur Respir Monogr 2021; 91: 290-305 Year: 2021 Mesenchymal stem cells and fibrotic lung diseases Source: International Congress 2014 – Targeting lung fibrosis: from bench to bedside Year: 2014 The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon Year: 2008 Identification of mesenchymal stromal cells in lung tissue from lung-transplanted patients Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: ERS Lung Science Conference 2021 Year: 2021 Mechanical programming of mesenchymal stromal cells to treat lung fibrosis Source: ERS Lung Science Conference 2018 Year: 2018 Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition Source: Eur Respir J 2015; 45: 1258-1272 Year: 2015 Mesenchymal stem cells in aging and IPF Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research Year: 2016 Bone marrow derived mesenchymal stem cells accelerate alveolar epithelial repair in vitro Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly? Year: 2007 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis Source: International Congress 2018 – Regenerative and anti-fibrotic approaches Year: 2018 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Primary bronchial epithelial cell culture from lung allografts Source: Annual Congress 2004 - Bronchiolitis obliterans: new developments in investigating post-transplant airway disease Year: 2004 Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype Source: Eur Respir Rev 2014; 23: 118-130 Year: 2014 Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease Source: Eur Respir Monogr 2021; 91: 205-221 Year: 2021 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 LATE-BREAKING ABSTRACT: Tissue-resident epithelial stem/progenitor cells in pulmonary epithelial repair Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015